Lung function tests, also known as pulmonary function test is used for the diagnosis of lung disorders such as asthma, respiratory infections, chronic obstructive pulmonary disease (COPD), and others. These group of tests also determine the functioning of the lungs, and the ability of a person to breath. They are also a part of tests for routine examination by the healthcare provider. The healthcare provider may recommend lung function tests to diagnose the suspected lung disease, plan the treatment, and decide whether to continue the ongoing treatment or change it and even to stop the treatment, if required. Therefore, lung function test plays a vital role in the diagnosis of various respiratory diseases, and lung disorders.
Due to the COVID-19 pandemic, the global Lung Function Tests Devices market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Lung Function Tests Devices market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Lung Function Tests Devices landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Spirometer accounting for % of the Lung Function Tests Devices global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospitals segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of Lung Function Tests Devices include BD (CareFusion), MGC Diagnostic, GE, Hill-Rom, Perkin Elmer, Carestream Health, Cosmed Srl and Nihon Kohden, etc. In terms of revenue, the global 3 largest players have a % market share of Lung Function Tests Devices in 2021.
This report focuses on Lung Function Tests Devices volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Lung Function Tests Devices market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Lung Function Tests Devices Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Spirometer
Breath CO Monitor
Oscillometer
Ergospirometer
Dose Controlled Drug Nebulizer
Others
Segment by Application
Hospitals
Clinics
Diagnostic Centers
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
BD (CareFusion)
MGC Diagnostic
GE
Hill-Rom
Perkin Elmer
Carestream Health
Cosmed Srl
Nihon Kohden